All changes made to the description and title of this division.

View division | Edit description

Change Division
representatives vote 2019-11-27#16

Edited by mackay

on 2019-12-27 14:33:47

Title

  • Bills — Social Security (Administration) Amendment (Income Management to Cashless Debit Card Transition) Bill 2019; Consideration in Detail
  • Social Security (Administration) Amendment (Income Management to Cashless Debit Card Transition) Bill 2019 - Consideration in Detail - Agree with bill as amended

Description

  • <p class="speaker">Tony Smith</p>
  • <p>The question now is that this bill, as amended, be agreed to.</p>
  • The majority voted in favour of a [motion](https://www.openaustralia.org.au/debate/?id=2019-11-27.151.1) "*that this bill, as amended, be agreed to.*" This ends the consideration in detail stage of the bill and means that our MPs can now discuss whether to pass the bill (that is, read it for a [third time](https://www.peo.gov.au/understand-our-parliament/how-parliament-works/bills-and-laws/making-a-law-in-the-australian-parliament/)).
  • ### What does the bill do?
  • The bill [was introduced in order to](https://www.aph.gov.au/Parliamentary_Business/Bills_Legislation/bd/bd1920a/20bd062):
  • > * *establish the Northern Territory (NT) and Cape York area as cashless debit card (CDC) trial areas and transition income management participants in these areas onto the cashless debit card trial in 2020*
  • > * *extend the end date for existing CDC trial sites from 30 June 2020 to 30 June 2021 and establish an end date of 30 June 2021 the proposed NT CDC trial site*
  • > * *establish an end date for the CDC trial in the Cape York area of 31 December 2021*
  • > * *remove the current cap of 15,000 CDC trial participants*
  • > * *enable people in the Bundaberg and Hervey Bay trial site to volunteer to participate in the trial*
  • > * *enable the Secretary of the Department of Social Services to advise a community body when a person has exited the CDC trial and*
  • > * *make changes to the CDC trial review and evaluation process.*